Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Frontiers in Bioscience-Landmark · 19.01.2024 · 29 (1)
DOI: 10.31083/j.fbl2901030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 19.01.2024. Verfasst von Shuangshuang Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Changchun University of Chinese Medicine, 130117 Changchun, Jilin, China. Hauptthemen laut MEDLINE: Ferroptosis, Metabolic Diseases, Carcinoma, Hepatocellular, Fatty Liver. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Development Plan of Jilin Province.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) has a global prevalence of 25% and is a leading cause of cirrhosis and hepatocellular carcinoma. The prevalence of MASLD has been increasing, mirroring the global increase in diabetes and metabolic syndrome. MASLD is a chronic and progressive condition characterized by inflammation, oxidative stress, insulin resistance, and disruptions in lipid metabolism. Programmed cell death (PCD) plays a pivotal role in determining the pathological aspects of MASLD, including liver inflammation, fibrosis, and even the potential for malignant transformation. PCD is a dominant process that is fundamental for eukaryotic growth and serves as a regulatory factor in MASLD. PCD encompasses various pathways, including autophagy, ferroptosis, apoptosis, and pyroptosis. These PCD pathways can be activated at different stages of MASLD. The key effector molecules involved in these processes are central focal points in the development of therapeutic interventions for MASLD. Here, we comprehensively review the idea that targeted the modulation of the PCD pathway may be an effective approach for the prevention and/or treatment of MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Clinical Medicine, Changchun University of Chinese Medicine, 130117 Changchun, Jilin, China.
- State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 130022 Changchun, Jilin, China.
Förderung
- Science and Technology Development Plan of Jilin Province
Zitieren
APA
Zhao, S., Guo, Y., & Yin, X. (2024). Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Frontiers in Bioscience-Landmark, 29(1). https://doi.org/10.31083/j.fbl2901030
Vancouver
Zhao S, Guo Y, Yin X. Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Frontiers in Bioscience-Landmark. 2024;29(1). doi:10.31083/j.fbl2901030
BibTeX
@article{Zhao2024,
author = {Zhao, Shuangshuang and Guo, Yan and Yin, Xunzhe},
title = {Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
volume = {29},
number = {1},
doi = {10.31083/j.fbl2901030}
}
EUVIMED